Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel + carboplatin versus docetaxel + carboplatin as first-line chemotherapy for epithelial ovarian cancer
ISRCTN31374767Phase 3Completed
- Sponsor
- Cancer Research UK
- Start
- Jan 1997
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
01
Overview
Phase 3, randomised, open-label trial in epithelial ovarian cancer (EOC) comparing Docetaxel + carboplatin with Paclitaxel + carboplatin (2 arms). Started Jan 1997; status: completed.
02
Drugs
paclitaxeldocetaxelcarboplatin
03
Conditions
epithelial ovarian cancer (EOC)
Beyond the preview
Go deeper on ISRCTN31374767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN31374767.